Reactive intermediates: Molecular and MS-based approaches to assess the functional significance of chemical-protein adducts

Toxicologic Pathology

Volumn 41, Issue 2, 2013, Pages 315-321

  Monks, Terrence J ^a   Lau, Serrine S ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

bioactivation; chemical induced toxicities; covalent binding; drug metabolism; protein adducts; proteomics; reactive intermediates

Indexed keywords

ELECTROPHILE;

ADDUCTION; ARTICLE; MASS SPECTROMETRY; METABOLIC ACTIVATION; MOLECULAR DYNAMICS; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN TARGETING;

ANIMALS; HUMANS; MASS SPECTROMETRY; MICE; MODELS, MOLECULAR; ORGANIC CHEMICALS; PROTEIN BINDING; PROTEINS; PROTEOMICS; TOXICITY TESTS;

EID: 84875743156     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623312467399     Document Type: Article

References (47)

1. Ahmed N., Argirov O. K., Minhas H. S., Cordeiro C. A., Thornalley P. J.. Assay of advanced glycation endproducts (AGEs): Surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N- hydroxysuccinimidyl- carbamate and application to N-epsilon-carboxymethyl- lysine- and N-epsilon-(1-carboxyethyl)lysine-modified albumin. Biochem J. 2002 ; 364: 1-14
2. Ahmed N., Dobler D., Dean M., Thornalley P. J.. Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity. J Biol Chem. 2005 ; 280: 5724-32
3. Banci L., Bertini I., Gray H. B., Luchinat C., Reddig T., Rosato A., Turano P.. Solution structure of oxidized horse heart cytochrome c. Biochemistry. 1997 ; 36: 9867-77
4. Beisswenger P. W.. Glycation and biomarkers of vascular complications of diabetes. Amino Acids. 2012 ; 42: 1171-83
5. Chaplen F. W. R., Fahl W. E., Cameron D. C.. Evidence of high levels of methylglyoxal in cultured Chinese hamster ovary cells. Proc Natl Acad Sci USA. 1998 ; 95: 5533-38
6. Dhar A., Desai K., Liu J., Wu L.. Methylglyoxal, protein binding and biological samples: Are we getting the true measure?. J Chromatogr B. 2009 ; 877: 1093-100
7. Dunlop M.. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int Suppl. 2000 ; 77: S3-12
8. Fisher A. A., Labenski M. T., Malladi S., Chapman J. D., Bratton S. B., Monks T. J., Lau S. S.. The frequency of 1,4-benzoquinone-lysine adducts in cytochrome c are associated with defects in apoptosome activation. Toxicol Sci. 2011 ; 122: 64-72
9. Fisher A. A., Labenski M. T., Malladi S., Gokhale V., Bowen M. E., Milleron R. S., Bratton S. B., Monks T. J., Lau S. S.. Quinone electrophiles selectively adduct "electrophile binding motifs" within cytochrome c. Biochemistry. 2007 ; 46: 11090-100
10. Fritz K. S., Petersen D. R.. Exploring the biology of lipid peroxidation-derived protein carbonylation. Chem Res Toxicol. 2011 ; 24: 1411-19
11. Galligan J. J., Smathers R. L., Fritz K. S., Epperson L. E., Hunter L. E., Petersen D. R.. Protein carbonylation in a murine model for early alcoholic liver disease. Chem Res Toxicol. 2012 ; 25: 1012-21
12. Galvin J. E.. Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: A case for the selective vulnerability of the substantia nigra. Acta Neuropathol. 2006 ; 112: 115-26
13. Grimsrud P. A., Xie H., Griffin T. H., Bernlohr D. A.. Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem. 2008 ; 283: 21837-41
14. Hansen B. T., Davey S. W., Ham A. J., Liebler D. C.. P-Mod: An algorithm and software to map modifications to peptide sequences using tandem MS data. J Proteome Res. 2005 ; 4: 358-368
15. Hanzlik R. P., Fang J., Koen Y. M.. Filing and mining the reactive metabolite target protein database. Chem Biol Interact. 2009 ; 179: 38-44
16. Iwao Y., Anraku M., Yamasaki K., Kragh-Hansen U., Kawai K., Maruyama T., Otagiri M.. Oxidation of Arg-410 promotes the elimination of human serum albumin. BBA-Proteins Proteomics. 2006 ; 1764: 743-49
17. Jack M., Wright D.. Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral neuropathy. Transl Res. 2012 ; 159: 355-65
18. Jacobs A. T., Marnett L. J.. Systems analysis of protein modification and cellular responses induced by electrophile stress. Acc Chem Res. 2011 ; 43: 673-83
19. Khuhawar M. Y., Zardari L. A., Laghari A. J.. Capillary gas chromatographic deter-mination of methylglyoxal from serum of diabetic patients by precolumn derivatization with 1,2-diaminopropane. J Chromatogr B: Anal Technol Biomed Life Sci. 2008 ; 873: 15-19
20. Kimzey M. J., Yassine H. N., Riepel B. M., Tsaprailis G., Monks T. J., Lau S. S.. New site(s) of methylglyoxal-modified human serum albumin, identified by multiple reaction monitoring, alter warfarin binding and prostaglandin metabolism. Chem Biol Interact. 2011 ; 192: 122-28
21. Labenski M. T., Fisher A. A., Lo H-H., Monks T. J., Lau S. S.. Protein electrophile binding motifs: Lysine rich proteins are preferential targets of quinones. Drug Metab Disp. 2009 ; 37: 1211-18
22. Lau S. S., Monks T. J., Everitt J. I., Kleymenova E., Walker C. W.. Carcinogenicity of a nephrotoxic metabolite of the "non-genotoxic" carcinogen hydroquinone. Chem Res Toxicol. 2001 ; 14: 25-33
23. Liebler D. C.. The poisons within: Application of toxicity mechanisms to fundamental disease processes. Chem Res Toxicol. 2006 ; 19: 610-13
24. Liebler D. C.. Protein damage by reactive electrophiles: Targets and consequences. Chem Res Toxicol. 2008 ; 21: 117-28
25. Liu X., Kim C. N., Yang J., Jemmerson R., Wang X.. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell. 1996 ; 86: 147-57
26. Luo X., Kraus W. L.. On PAR with PARP: Cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes and Dev. 2012 ; 26: 417-32
27. Mark R. J., Lovell M. A., Markesbery W. R., Uchida K., Mattson M. P.. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J Neurochem. 1997 ; 68: 255-64
28. Miyake H., Kadoya A, Ohyashiki T.. Increase in molecular rigidity of the protein conformation of brain Na+-K+-ATPase by modification with 4-hydroxy-2-nonenal. Biol Pharm Bull. 2003 ; 26: 1652-56
29. Osawa Y., Korzekwa K.. Oxidative modification by low levels of HOOH can transform myoglobin to an oxidase. Proc Natl Acad Sci USA. 1991 ; 88: 587-94
30. Park B. K., Boobis A., Clarke S., Goldring C. E. P., Jones D. J., Kenna J. G., Lambert C., Laverty H. G., Naisbitt D. J., Nelson S., Nicoll-Griffith D. A., Obach R. S., Routledge P., Smith D. A., Tweedle D. J., Vermeulen N., Williams D. P., Wilson I. D., Bailiie T. A.. Managing the challenge of chemically reactive metabolites in drug development. Nat Rev Drug Discov. 2011 ; 10: 292-306
31. Perluigi M., Coccia R., Butterfield D. A.. 4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: A toxic combination illuminated by redox proteomics studies. Antioxd Redox Signal. 2012 ; 17: 1590-1609
32. Person M. D., Monks T. J., Lau S. S.. An integrated approach to identifying chemically induced post-translational modifications using comparative MALDI-MS and targeted HPLC-ESI-MS/MS. Chem Res Toxicol. 2003 ; 16: 598-608
33. Person M. D., Mason D. E., Liebler D. C., Monks T. J., Lau S. S.. Alkylation of cytochrome c by (glutathion-S-yl)-1,4-benzoquinone and iodoacetamide demonstrates compound dependent site specificity. Chem Res Toxicol. 2005 ; 18: 41-50
34. Pohl L. R.. An immunochemical approach of identifying and characterizing protein targets of reactive metabolites. Chem Res Toxicol. 1993 ; 6: 786-93
35. Rabbani N., Thornalley P. J.. Glyoxalase in diabetes, obesity and related disorders. Semin Cell Dev Biol. 2011 ; 22: 309-17
36. Ruiperez V., Darios F., Davietov B.. Alpha-synuclein, lipids and Parkinson's disease. Prog Lipid Res. 2010 ; 49: 420-28
37. Satoh H., Fukuda Y., Anderson D. K., Ferrans V. J., Gillette J. R., Pohl L. R.. Immunological studies on the mechanism of halothane-induced hepatotoxicity; immunohistochemical evidence for trifluoroacetylated hepatocytes. J Pharmacol Exp Ther. 1985 ; 233: 857-62
38. Satoh H., Martin B. M., Schulick A.H, Christ D. D., Kenna J. G., Pohl L. R.. Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase. Proc Natl Acad Sci USA. 1989 ; 86: 322-26
39. Sidell K. R., Amamath V., Montine T. J.. Dopamine thioethers in neurodegeneration. Curr Top Med Chem. 2001 ; 1: 519-27
40. Singh J., Petter R. C., Baillie T. A., andWhitty A.. The resurgence of covalent drugs. Nat Rev Drug Discov. 2011 ; 10: 307-17
41. Stepan A. F., Walker D. P., Bauman J., Price D. A., Baillie T. A., Kalgutkar A. S., Aleo M. D.. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: A perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. Chem Res Toxicol. 2011 ; 24: 1345-410
42. Stitt A. W., Frizzell N., Thorpe S. R.. Advanced glycation and advanced lipoxidation: Possible role in initiation and progression of diabetic retinopathy. Curr Pharm Des. 2004 ; 10: 3349-60
43. Thornalley P. J.. Pharmacology of methylglyoxal: Formation, modification of proteins and nucleic acids, and enzymatic detoxification - a role in pathogenesis and antiproliferative chemotherapy. Gen Pharmacol. 1996 ; 27: 565-73
44. Thornalley P. J., Rabbani N.. Highlights and hotspots of protein glycation in end-stage renal disease. Semin Dial. 2009 ; 22: 400-4
45. Yang J. S., Petersen C. E., Ha C. E., Bhagavan N. V.. Structural insights into human serum albumin-mediated prostaglandin catalysis. Protein Sci. 2002 ; 11: 538-45
46. Yu T., Wang X., Purring-Koch C., Wei Y., McLendon G. L.. A mutational epitope for cytochrome c binding to the apoptosis protease activation factor-1. J Biol Chem. 2001 ; 276: 13034-38
47. Zou H., Henzel W. J., Liu X., Lutschg A., Wang X.. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 1997 ; 90: 405-413